AD Detect-Prevent holds first steering committee meeting

Members of the steering committee and project partners met in Copenhagen on 22 March to discuss progress with the AD Detect-Prevent project. This project aims to develop for the clinical and mass market an easily accessible, user-friendly and motivating digital medical device, which can be used on tablets, smartphones and PCs/Mac for the presymptomatic detection of AD. In addition, personalised AD prevention programmes will be developed in the form of computerised cognitive training and behavioural/lifestyle interventions in one seamless product. The meeting provided an opportunity to align the different work streams, discuss overriding issues related to terminology, motivation, potential target groups and possible areas to focus on for the prevention programmes. Dianne Gove, Director for Projects, attended the meeting. This project is funded by the European Union’s Horizon 2020 research and innovation programme – Fast Track to Innovation (FTI), grant agreement 820636.